CURRENT ACADEMIC ROLE & RESPONSIBILITIES
Dr. Ruchi Verma is an Assistant professor-Senior Lecturer in the department of Pharmaceutical Chemistry.
She conducts both theory and practicals of Pharmaceutical Chemistry for BPharm, PharmD and MPharm students.
SUBJECTS CURRENTLY TEACHING
|Subject||Semester / Year|
|Pharmaceutical Inorganic Chemistry||First year PharmD|
|Pharmaceutical Inorganic Chemistry||First Semester BPharm|
|Pharmaceutical Chemistry-I||First Year DPharm|
|Pharmaceutical Chemistry Practicals-I||First Semester MPharm|
|Herbal and Cosmetic Analysis||Second Semester MPharm (Pharmaceutical Analysis)|
|Pharmaceutical Analysis Practicals-II||Second Semester MPharm|
|Degree||Specialisation||Institute||Year of passing|
|M.Pharm||Pharmaceutical Chemistry||North Bengal Uniiversity||2009|
|B.Pharm||HNB Gharwal University, Uttarakhand||2007|
|Institution / Organisation||Designation||Role||Tenure|
|Department of Pharmaceutical Chemistry, MCOPS, Manipal Academy of Higher Education||Assistant professor-Senior Scale||2015- till date|
|Department of Pharmaceutical Chemistry, MCOPS, Manipal Academy of Higher Education||Assistant Professor||2010-14|
|Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal Academy of Higher Education, Tadong, Gangtok, East Sikkim, India||Lecturer||2010|
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Organic Chemistry, Drug designing, Synthetic and Natural Chemistry
Area of Expertise
Area of Research
Anti-Tubercular Drug design
Professional Affiliations & Contributions
- Registered Pharmacist, Himachal Pradesh State Pharmacy Council, 2013.
- Life Member of Association of Pharmaceutical Teachers of India, 2008.
- Life Member of International Associations of Academicians and Researchers, 2013.
Design, molecular docking, ADME analysis and molecular dynamics studies of novel acetylated schiff bases as COX-2 inhibitors
July 2020 Lohith T N Ruchi Verma Lohith Kumar
Research Journal of Pharmacy and Technology, 13 (4). pp. 1901-1906 (Impact factor: 0.5)
Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy]benzyl) arylamine derivatives as potential antitubercular agents
Drug Development Research, 81 (3). pp. 315-328. ISSN 1098-2299 (Impact factor: 1.902)